The long-term objective of the UCSD Acute Lung Injury (ALI) SCOR continues to be generation of insights that will lead to reduction in the morbidity and mortality associated with ALI, with attention focused specifically on investigations on lung injury mechanisms that might lead to design of rational therapies.
The specific aims of this application are to continue research activities in six distinct area that address the primary SCOR objective and to maintain and expand the interactive, synergistic intra-SCOR relationships that currently exist. Five projects continue and will expand their current SCOR programs, while a new project complements existing efforts. Studies will continue using a unique clinical model of ALI (patients undergoing pulmonary thrombo-endarterectomy) that is temporally and clinically predictable, and thus provides a singular opportunity to study targeted interventions. Fundamental observations of surfactant apoprotein B structure/function relationships underlie design of a synthetic surfactant, and studies to optimize that surfactant composition, and studies to optimize that surfactant composition and delivery and to understand anti-inflammatory potential will be performed; in addition, a variety of approaches aimed at inhibition of IL-8 activity will be evaluated. Mechanisms by which surfactant modulates the phagocyte respiratory burst oxidase will be explored in detail, with the goal of developing strategies to prevent or ameliorate, ALI; a novel strategy to reach this goal by expanding surfactant phospholipid pools through expression of a phosphocholine cytidylyltransferase transgene will also be explored. Having discovered that selectin-carbohydrate interactions involve heparan sulfate, investigators will now study interactions involve heparan sulfate, investigators will now study lung L- and P-selectin expression in acute lung injury and the potential of heparin and related molecules to modify selectin interaction with native ligands. Investigators will identify and assess function of specific receptors that affect interactions between lung cells and bacterial lipopolysaccharide- protein complexes and, in a new project, the role of parathyroid hormone- related protein (PTHrP) in modifying type II cell function, growth, and apoptosis will be studied. Clinical, Tissue and Cell Laboratory, and Administrative Cores support SCOR activities; the last takes particular care to maintain and expand intra-SCOR collaborations.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL023584-24
Application #
6476720
Study Section
Special Emphasis Panel (ZHL1-CSR-H (M1))
Program Officer
Harabin, Andrea L
Project Start
1978-12-01
Project End
2003-11-30
Budget Start
2001-12-01
Budget End
2002-11-30
Support Year
24
Fiscal Year
2002
Total Cost
$1,270,165
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Kerr, Kim M; Auger, William R; Marsh, James J et al. (2012) Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy. Chest 141:27-35
Dunzendorfer, Stefan; Lee, Hyun-Ku; Soldau, Katrin et al. (2004) Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J 18:1117-9
Lee, Hyun-Ku; Dunzendorfer, Stefan; Tobias, Peter S (2004) Cytoplasmic domain-mediated dimerizations of toll-like receptor 4 observed by beta-lactamase enzyme fragment complementation. J Biol Chem 279:10564-74
Spragg, Roger G; Ponganis, Paul J; Marsh, James J et al. (2004) Surfactant from diving aquatic mammals. J Appl Physiol 96:1626-32
Dunzendorfer, Stefan; Lee, Hyun-Ku; Soldau, Katrin et al. (2004) TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J Immunol 173:1166-70
Spragg, Roger G; Lewis, James F; Wurst, Wilhelm et al. (2003) Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med 167:1562-6
Thompson, Patricia A; Tobias, Peter S; Viriyakosol, Suganya et al. (2003) Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J Biol Chem 278:28367-71
Tapping, Richard I; Tobias, Peter S (2003) Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. J Endotoxin Res 9:264-8
Bussolati, Benedetta; David, Salvatore; Cambi, Vincenzo et al. (2002) Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS. Int J Mol Med 10:441-9
Li, Jiali; Marsh, James J; Spragg, Roger G (2002) Effect of CTP:phosphocholine cytidylyltransferase overexpression on the mouse lung surfactant system. Am J Respir Cell Mol Biol 26:709-15

Showing the most recent 10 out of 107 publications